Study of the Role of Genetic Modifiers in Hemoglobinopathies

IsraelRecruiting

Conditions

Sickle Cell Disease · Thalassemia, Beta · Thalassemia Alpha · Hemoglobinopathies

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Boston Children's Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Natasha Archer, MD)
  • Lucrecia Paím Maternity, Luanda, Angola

    Contact: Study coordinator (Ligia Alves)
  • University of Buenos Aires, Buenos Aires, Argentina

    Contact: Study coordinator (Karen Scheps, PhD)
  • University Hospitals Leuven, Leuven, Belgium

    Contact: Study coordinator (Veerle Labarque, MD, PhD)
  • Universiti Brunei Darussalam, Brunei, Brunei

    Contact: Study coordinator (Mas Rina Wati Abdul Hamid)
  • Larnaca General Hospital, Larnaca, Cyprus

    Contact: Study coordinator (Maria Sitarou, MD)
  • Limassol General Hospital, Limassol, Cyprus

    Contact: Study coordinator (Michael Hadjigavriel, MD)
  • Archbishop Makarios III Hospital, Nicosia, Cyprus

    Contact: Study coordinator (Soteroula Christou, MD)
  • Paphos General Hospital, Paphos, Cyprus

    Contact: Study coordinator (Thomas Dimitriou, MD)
  • Centre Hospitalier Monkole, Kinshasa, Democratic Republic of the Congo

    Contact: Study coordinator (Leon Tshilolo, MD)
  • Rigshospitalet, Copenhagen, Denmark

    Contact: Study coordinator (Andreas Birkedal Glenthøj, MD)
  • Hippokrateio Hospital of Athens, Athens, Greece

    Contact: Study coordinator (Sophia Delicou, MD)
  • Laiko General Hospital, Athens, Greece

    Contact: Study coordinator (Maria Dimopoulou, MD)
  • National and Kapodistrian University of Athens, Athens, Greece

    Contact: Study coordinator (Joanne Traeger-Synodinos, PhD)
  • General Hospital of Larissa, Larissa, Greece

    Contact: Study coordinator (Michael Diamantidis, MD)
  • Emek Medical Centre, Afula, Israel

    Contact: Study coordinator (Ariel Koren, MD)
  • University of Turin, Turin, Italy

    Contact: Study coordinator (Giorgia Mandrile, PhD)
  • Ampang Hospital, Ampang, Malaysia

    Contact: Study coordinator (Veena Selvaratnam, MD)
  • Universiti Kebangsaan Malaysia, Bangi, Malaysia

    Contact: Study coordinator (Raja Zahratul Azma, MD)
  • Universiti Sains Malaysia, Kota Bharu, Malaysia

    Contact: Study coordinator (Bin Alwi Zilfalil, MD, PhD)
  • University of Abuja, Abuja, Nigeria

    Contact: Study coordinator (Obiageli E Nnodu, MD)
  • Kaduna State University, Kaduna, Nigeria

    Contact: Study coordinator (Livingstone Dogara, MD)
  • Ahmadu Bello University, Zaria, Nigeria

    Contact: Study coordinator (Aliyu Waziri, MD)
  • University of Lahore, Lahore, Pakistan

    Contact: Study coordinator (Ahmed Bilal, PhD)
  • Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal

    Contact: Study coordinator (Celeste Bento, PhD)
  • Hospital Clínico San Carlos, Madrid, Spain

    Contact: Study coordinator (Paloma Ropero, PhD)
Study leads
  • Petros Kountouris, PhD

    Principal Investigator

    Cyprus Institute of Neurology and Genetics